Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors
Public ClinicalTrials.gov record NCT05383872. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Pivotal Study to Evaluate the Safety and Effectiveness of Exablate Model 4000 Using Microbubble Resonators to Temporarily Mediate Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors
Study identification
- NCT ID
- NCT05383872
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- InSightec
- Industry
- Enrollment
- 71 participants
Conditions and interventions
Conditions
Interventions
- Focused Ultrasound (Exablate Model 4000) Device
Device
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 7, 2022
- Primary completion
- Feb 20, 2025
- Completion
- Mar 4, 2025
- Last update posted
- Jul 27, 2025
2022 – 2025
United States locations
- U.S. sites
- 16
- U.S. states
- 8
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California, Los Angeles | Los Angeles | California | 90095 | — |
| Hoag Memorial Hospital Presbyterian | Newport Beach | California | 92618 | — |
| University of California San Francisco | San Francisco | California | 94107 | — |
| UF Health Shands Hospital | Gainesville | Florida | 32608 | — |
| Miami Cancer Institute at Baptist Health | Miami | Florida | 33176 | — |
| Tampa General Hospital | Tampa | Florida | 33606 | — |
| Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| University of Maryland, Baltimore & The University of Maryland Medical System | Baltimore | Maryland | 21201 | — |
| Johns Hopkins University | Baltimore | Maryland | 21218 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| NYU Grossman School of Medicine | New York | New York | 10016 | — |
| University of North Carolina | Chapel Hill | North Carolina | 27516 | — |
| Duke University | Durham | North Carolina | 27710 | — |
| University of Texas, Southwestern | Dallas | Texas | 75390 | — |
| University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| West Virginia University Rockefeller Neuroscience Center | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05383872, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 27, 2025 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05383872 live on ClinicalTrials.gov.